Cargando…

Low Birth Weight Is a Risk Factor for Severe Retinopathy of Prematurity Depending on Gestational Age

OBJECTIVE: To evaluate the impact of low birth weight as a risk factor for retinopathy of prematurity (ROP) that will require treatment in correlation with gestational age at birth (GA). STUDY DESIGN: In total, 2941 infants born <32 weeks GA were eligible from five cohorts of preterm infants prev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lundgren, Pia, Kistner, Anna, Andersson, Eva M., Hansen Pupp, Ingrid, Holmström, Gerd, Ley, David, Niklasson, Aimon, Smith, Lois E. H., Wu, Carolyn, Hellström, Ann, Löfqvist, Chatarina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198133/ https://www.ncbi.nlm.nih.gov/pubmed/25330287 http://dx.doi.org/10.1371/journal.pone.0109460

Ejemplares similares

Neonatal IGF-1/IGFBP-1 axis and retinopathy of prematurity are associated with increased blood pressure in preterm children
por: Kistner, Anna, et al.
Publicado: (2014)

Increased postnatal concentrations of pro-inflammatory cytokines are associated with reduced IGF-I levels and retinopathy of prematurity
por: Hellgren, Gunnel, et al.
Publicado: (2017)

Analysis of Brain Injury Biomarker Neurofilament Light and Neurodevelopmental Outcomes and Retinopathy of Prematurity Among Preterm Infants
por: Sjöbom, Ulrika, et al.
Publicado: (2021)

Low postnatal serum IGF-I levels are associated with bronchopulmonary dysplasia (BPD)
por: Löfqvist, Chatarina, et al.
Publicado: (2012)

IGF1, serum glucose, and retinopathy of prematurity in extremely preterm infants
por: Cakir, Bertan, et al.
Publicado: (2020)

WINROP Identifies Severe Retinopathy of Prematurity at an Early Stage in a Nation-Based Cohort of Extremely Preterm Infants
por: Lundgren, Pia, et al.
Publicado: (2013)

Individual Risk Prediction for Sight-Threatening Retinopathy of Prematurity Using Birth Characteristics
por: Pivodic, Aldina, et al.
Publicado: (2019)

Implementing higher oxygen saturation targets reduced the impact of poor weight gain as a predictor for retinopathy of prematurity
por: Lundgren, Pia, et al.
Publicado: (2017)

Longitudinal Serum Metabolomics in Extremely Premature Infants: Relationships With Gestational Age, Nutrition, and Morbidities
por: Nilsson, Anders K., et al.
Publicado: (2022)

Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomized Clinical Trial
por: Hellström, Ann, et al.
Publicado: (2021)

Unpasteurised maternal breast milk is positively associated with growth outcomes in extremely preterm infants
por: Lund, Anna‐My, et al.
Publicado: (2019)

Association of Docosahexaenoic Acid and Arachidonic Acid Serum Levels With Retinopathy of Prematurity in Preterm Infants
por: Hellström, Ann, et al.
Publicado: (2021)

Prognostic Value of Parenteral Nutrition Duration on Risk of Retinopathy of Prematurity: Development and Validation of the Revised DIGIROP Clinical Decision Support Tool
por: Pivodic, Aldina, et al.
Publicado: (2023)

Costs associated with retinopathy of prematurity: a systematic review and meta-analysis
por: Gyllensten, Hanna, et al.
Publicado: (2022)

Validation of DIGIROP models and decision support tool for prediction of treatment for retinopathy of prematurity on a contemporary Swedish cohort
por: Pivodic, Aldina, et al.
Publicado: (2023)

High rate and large intercentre variability in retreatment of retinopathy of prematurity in infants born <24 gestational weeks
por: Lundgren, Pia, et al.
Publicado: (2021)

Development and validation of a new clinical decision support tool to optimize screening for retinopathy of prematurity
por: Pivodic, Aldina, et al.
Publicado: (2022)

IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development
por: Hellström, Ann, et al.
Publicado: (2017)

Evaluation of the Retinopathy of Prematurity Activity Scale (ROP-ActS) in a randomised controlled trial aiming for prevention of severe ROP: a substudy of the Mega Donna Mega trial
por: Pivodic, Aldina, et al.
Publicado: (2022)

Association of Retinopathy of Prematurity With Low Levels of Arachidonic Acid: A Secondary Analysis of a Randomized Clinical Trial
por: Löfqvist, Chatarina A., et al.
Publicado: (2018)

Low energy intake during the first 4 weeks of life increases the risk for severe retinopathy of prematurity in extremely preterm infants
por: Stoltz Sjöström, Elisabeth, et al.
Publicado: (2016)

Decreased Platelet Counts and Serum Levels of VEGF-A, PDGF-BB, and BDNF in Extremely Preterm Infants Developing Severe ROP
por: Hellgren, Gunnel, et al.
Publicado: (2021)

Modification of serum fatty acids in preterm infants by parenteral lipids and enteral docosahexaenoic acid/arachidonic acid: A secondary analysis of the Mega Donna Mega trial
por: Sjöbom, Ulrika, et al.
Publicado: (2023)

Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: A randomized controlled trial
por: Najm, Svetlana, et al.
Publicado: (2017)

Serum choline in extremely preterm infants declines with increasing parenteral nutrition
por: Nilsson, Anders K., et al.
Publicado: (2020)

Insulin‐like growth factor 1 has multisystem effects on foetal and preterm infant development
por: Hellström, Ann, et al.
Publicado: (2016)

Association between low fatty acid levels and platelet count in infants with Retinopathy of Prematurity
por: Lundgren, Pia, et al.
Publicado: (2020)

Correspondence to “Prediction of severe retinopathy of prematurity in 24–30 weeks gestation infants using birth characteristics”
por: Pivodic, Aldina, et al.
Publicado: (2021)

Retinopathy of prematurity: the need for prevention
por: Liegl, Raffael, et al.
Publicado: (2016)

Sphingolipidomics of serum in extremely preterm infants: Association between low sphingosine-1-phosphate levels and severe retinopathy of prematurity
por: Nilsson, Anders K., et al.
Publicado: (2021)

Systematic review of the healthcare cost of bronchopulmonary dysplasia
por: Humayun, Jhangir, et al.
Publicado: (2021)

Retinopathy of prematurity: Metabolic risk factors
por: Fu, Zhongjie, et al.
Publicado: (2022)

Visual outcome at 2.5 years of age in ω-3 and ω-6 long-chain polyunsaturated fatty acid supplemented preterm infants: a follow-up of a randomized controlled trial
por: Lundgren, Pia, et al.
Publicado: (2023)

National cohort of infants born before 24 gestational weeks showed increased survival rates but no improvement in neonatal morbidity
por: Lundgren, Pia, et al.
Publicado: (2022)

Hyper high haemoglobin content in red blood cells and erythropoietic transitions postnatally in infants of 22 to 26 weeks’ gestation: a prospective cohort study
por: Larsson, Sara Marie, et al.
Publicado: (2023)

Continuous growth reference from 24(th )week of gestation to 24 months by gender
por: Niklasson, Aimon, et al.
Publicado: (2008)

Low fraction of fetal haemoglobin is associated with retinopathy of prematurity in the very preterm infant
por: Hellström, William, et al.
Publicado: (2022)

Prevalence of Severe Visual Disability Among Preterm Children With Retinopathy of Prematurity and Association With Adherence to Best Practice Guidelines
por: Norman, Mikael, et al.
Publicado: (2019)

Blood protein profiles related to preterm birth and retinopathy of prematurity
por: Danielsson, Hanna, et al.
Publicado: (2021)

Models predicting the growth response to growth hormone treatment in short children independent of GH status, birth size and gestational age
por: Dahlgren, Jovanna, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_qf8li1ido91kqci5gps9tji0mo